SB206 4%: Clinical Trials

1 trial of SB206 4%, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1

Follow SB206 4%: new trials by email Literature Review of SB206 4% trials Research Report on SB206 4%

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Evaluate the Safety and Efficacy of SB206 in Subjects With Molluscum Contagiosum
SB206 4%, SB206 8%, SB206 12% - Molluscum Contagiosum
Phase 2CompletedNovan, Inc.2562018-01-242023-05-06

Conditions studied

Molluscum Contagiosum (1)

Sponsors

Novan, Inc. (1)

Countries

United States (1)

Top investigators

Tomoko Maeda-Chubachi, MD (1)